Suppr超能文献

系统生物学与肾脏疾病。

Systems Biology and Kidney Disease.

机构信息

Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.

出版信息

Clin J Am Soc Nephrol. 2020 May 7;15(5):695-703. doi: 10.2215/CJN.09990819. Epub 2020 Jan 28.

Abstract

The kidney is a complex organ responsible for maintaining multiple aspects of homeostasis in the human body. The combination of distinct, yet interrelated, molecular functions across different cell types make the delineation of factors associated with loss or decline in kidney function challenging. Consequently, there has been a paucity of new diagnostic markers and treatment options becoming available to clinicians and patients in managing kidney diseases. A systems biology approach to understanding the kidney leverages recent advances in computational technology and methods to integrate diverse sets of data. It has the potential to unravel the interplay of multiple genes, proteins, and molecular mechanisms that drive key functions in kidney health and disease. The emergence of large, detailed, multilevel biologic and clinical data from national databases, cohort studies, and trials now provide the critical pieces needed for meaningful application of systems biology approaches in nephrology. The purpose of this review is to provide an overview of the current state in the evolution of the field. Recent successes of systems biology to identify targeted therapies linked to mechanistic biomarkers in the kidney are described to emphasize the relevance to clinical care and the outlook for improving outcomes for patients with kidney diseases.

摘要

肾脏是一个复杂的器官,负责维持人体的多种内环境稳定。不同细胞类型之间独特而又相互关联的分子功能的结合,使得与肾脏功能丧失或下降相关的因素的划定具有挑战性。因此,在管理肾脏疾病方面,临床医生和患者可获得的新诊断标志物和治疗选择非常有限。系统生物学方法可以理解肾脏,它利用计算技术和方法的最新进展来整合不同的数据组。它有潜力揭示多个基因、蛋白质和分子机制之间的相互作用,这些基因、蛋白质和分子机制推动着肾脏健康和疾病的关键功能。来自国家数据库、队列研究和试验的大型、详细、多层次的生物和临床数据的出现,为系统生物学方法在肾脏病学中的有意义应用提供了必要的关键部分。本文的目的是提供该领域发展现状的概述。描述了系统生物学在识别与肾脏机制生物标志物相关的靶向治疗方面的最新成功案例,以强调其与临床护理的相关性以及改善肾脏疾病患者预后的前景。

相似文献

1
Systems Biology and Kidney Disease.系统生物学与肾脏疾病。
Clin J Am Soc Nephrol. 2020 May 7;15(5):695-703. doi: 10.2215/CJN.09990819. Epub 2020 Jan 28.
2
The nephrologist of tomorrow: towards a kidney-omic future.未来的肾脏病学家:迈向肾脏组学的未来。
Pediatr Nephrol. 2017 Mar;32(3):393-404. doi: 10.1007/s00467-016-3357-x. Epub 2016 Mar 9.
5
Big science and big data in nephrology.肾脏病学中的大科学和大数据。
Kidney Int. 2019 Jun;95(6):1326-1337. doi: 10.1016/j.kint.2018.11.048. Epub 2019 Mar 5.
8
Systems biology of kidney diseases.肾脏疾病的系统生物学。
Kidney Int. 2012 Jan;81(1):22-39. doi: 10.1038/ki.2011.314. Epub 2011 Aug 31.
9
Pilot Study of Return of Genetic Results to Patients in Adult Nephrology.成人肾脏病患者遗传检测结果返还的初步研究。
Clin J Am Soc Nephrol. 2020 May 7;15(5):651-664. doi: 10.2215/CJN.12481019. Epub 2020 Apr 16.

引用本文的文献

2
Advances in kidney disease: pathogenesis and therapeutic targets.肾病进展:发病机制与治疗靶点
Front Med (Lausanne). 2025 Feb 14;12:1526090. doi: 10.3389/fmed.2025.1526090. eCollection 2025.
3
Advances in Diagnosis and Treatment of Inherited Kidney Diseases in Children.儿童遗传性肾脏病的诊断与治疗进展
Kidney Dis (Basel). 2024 Sep 24;10(6):558-572. doi: 10.1159/000541564. eCollection 2024 Dec.
7
N6-methyladenosine methylation in kidney injury.肾脏损伤中的N6-甲基腺苷甲基化
Clin Epigenetics. 2023 Oct 21;15(1):170. doi: 10.1186/s13148-023-01586-7.
8
The role of N6-methyladenosine (mA) in kidney diseases.N6-甲基腺苷(m6A)在肾脏疾病中的作用。
Front Med (Lausanne). 2023 Sep 28;10:1247690. doi: 10.3389/fmed.2023.1247690. eCollection 2023.
9
Chronic kidney disease and gut microbiota.慢性肾脏病与肠道微生物群
Heliyon. 2023 Aug 7;9(8):e18991. doi: 10.1016/j.heliyon.2023.e18991. eCollection 2023 Aug.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验